WCA
TMO icon

Waypoint Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Waypoint Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-381
Closed -$207K – 118
2022
Q2 		$207K Buy
381
+15
+4% +$8.26K 0.09% 110
2022
Q1 		$218K Buy
+366
New +$210K 0.13% 107

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Waypoint Capital Advisors's TMO Position: Q3 2022 in Review

Waypoint Capital Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2022, closing a stake of 381 shares — an estimated $207K sold.

Waypoint Capital Advisors first reported a position in TMO in Q1 2022 and held it in 2 quarters. The position peaked at $218K in Q1 2022. 2,268 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Waypoint Capital Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2022 after selling out during the quarter.
  • Waypoint Capital Advisors sold 381 Thermo Fisher Scientific shares in Q3 2022, an estimated $207K.
  • Waypoint Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 2 quarters.
  • Waypoint Capital Advisors's Thermo Fisher Scientific position peaked at $218K in Q1 2022.
  • 2,268 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Waypoint Capital Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.